Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection

BACKGROUND & AIMS: Less than 10% of registered drug intervention trials for pancreatic ductal adenocarcinoma (PDAC) include a biomarker stratification strategy. The ability to identify distinct mutation subsets via endoscopic ultrasound fine needle aspiration (EUS FNA) molecular cytology could g...

Descripción completa

Detalles Bibliográficos
Autores principales: Gleeson, Ferga C., Kerr, Sarah E., Kipp, Benjamin R., Voss, Jesse S., Minot, Douglas M., Tu, Zheng Jin, Henry, Michael R., Graham, Rondell P., Vasmatzis, George, Cheville, John C., Lazaridis, Konstantinos N., Levy, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342360/
https://www.ncbi.nlm.nih.gov/pubmed/27203738
http://dx.doi.org/10.18632/oncotarget.9440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342360/
https://www.ncbi.nlm.nih.gov/pubmed/27203738
http://dx.doi.org/10.18632/oncotarget.9440

Ejemplares similares